STEMI (ST Elevation Myocardial Infarction)
STEMI is a severe type of heart attack caused by a complete blockage of a coronary artery, leading to significant damage to the heart muscle. It requires immediate medical attention.
We are studying whether the medication Dabigatran helps patients with blood clots in the heart after a heart attack recover better than a traditional treatment. This trial looks at how well each treatment resolves the clot and prevents complications.
Health conditions and diseases that the clinical trial is designed to study and treat.
STEMI is a severe type of heart attack caused by a complete blockage of a coronary artery, leading to significant damage to the heart muscle. It requires immediate medical attention.
Left ventricular thrombosis occurs when a blood clot forms in the left ventricle of the heart, often as a complication of a heart attack or heart failure, which can lead to serious health issues.
These questions help us understand your situation so we can let the trial team know whether you might be a potential match. This is not a medical evaluation and is not part of the official screening, the study doctor will make the final decision..
Don't worry if you don't know the medicines tested in the trial. There is a chance you have heard about the similar medicines. Check the list below to see if you are familiar with any of them.
Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.
Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.